Industry experts share their experiences, including why and how cellular source materials are cryopreserved, the gold standard of cryo practices, and why experience across cell types and methods matters.
Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.
Discover the advantages of LFHCs, including improved solubility and bioavailability, enhanced stability, and customizable release profiles, and how they can accelerate drug development timelines.
Learn how CROs and CDMOs work in tandem to address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.
Learn more about the benefits of nanomilling, types of milling media and stabilizers, and scale up for clinical manufacturing.
Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
What makes a next-generation CHO bioproduction process? Take a journey through areas of innovation for creating expression systems of the future, with a focus on DNA and cell expression technologies.
Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.
Get the latest articles from Outsourced Pharma delivered to your inbox.